Hazelden Betty Ford Foundation

Founded 2014
Location
Locations
Origins Merger of the Hazelden Foundation and the Betty Ford Center
Services Addiction recovery
Key people
 Mark Mishek (CEO)
Website www.hazeldenbettyford.org

The Hazelden Betty Ford Foundation is an addiction treatment and advocacy organization that was created in 2014 with the merger of the Minnesota-based Hazelden Foundation and the Betty Ford Center in Rancho Mirage, California in the United States.[1]

The organizations have a long history together. Hazelden was founded in 1949, and Betty Ford herself visited its Minnesota headquarters in 1982 when she was planning to open the facility in Rancho Mirage.[2]

The Hazelden Betty Ford Foundation bases its residential and outpatient services on a Twelve Step, abstinence-based treatment model for individuals with addiction to alcohol and other drugs.[3]

The Foundation also includes the nation's largest addiction and recovery publishing house, a fully accredited graduate school of addiction studies, an addiction research center, prevention training and an education arm for medical professionals, family members and other loved ones, as well as a children's program.

References

  1. ↑ http://www.hazeldenbettyford.org/
  2. ↑ Terhune, Chad (2014-03-23). "Betty Ford Center ready for a comeback". Los Angeles Times. Retrieved 2017-07-24.
  3. ↑ Enos, Gary A. (2015-05-19). "Hazelden Betty Ford wants more patients in intensive opioid program with extended meds". Addiction Professional. Retrieved 2017-07-24.
  1. Quenqua, Douglas (June 5, 2013). "Betty Ford Center and Hazelden seek business partnership". The New York Times.
  2. Terhune, Chad (March 23, 2014). "Betty Ford Center ready for a comeback". Los Angeles Times.
  3. Enos, Gary A. (October 1, 2013). "Hazelden CEO: Health reform a major driver of merger with Betty Ford". Addiction Professional Magazine.
  4. Sanchez, Tatiana (February 11, 2014). "Mark Mishek named Hazelden Betty Ford Foundation CEO". Desert Sun.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.